Clinical Trial

Pro- and Anti-inflammatory Cytokines in PCOS

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 18, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The study will involve measurements and comparisons of the concentrations of pro-inflammatory cytokines: IL-6, TNF-α, IL-18, as well as anti-inflammatory cytokine IL-4 in women with polycystic ovary syndrome (PCOS) and insulin resistance, women with polycystic ovary syndrome without carbohydrate metabolism disorders, and women without PCOS (control group).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-01-20; most recent amendment 2026-03-17.
Trial Details
NCT Number NCT06793085
Lead Sponsor Jagiellonian University
Conditions Reproductive Age, PCOS (Polycystic Ovary Syndrome)
Enrollment 100 participants
Start Date 2025-01-20
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-18